Contribute Try STAT+ Today

WASHINGTON — Ten months into his tenure, President Biden has yet to nominate anyone to helm the Food and Drug Administration. But key new details about who’s helping to handle the interviews and which candidates have taken meetings shed some light on where the process stands.

Biden himself kicked off wide speculation about who might direct the agency last week, when he told reporters that he’d weigh in on a nominee for the agency “in a little bit.” Throughout his presidency, Acting Commissioner Janet Woodcock, an agency veteran, has been at the helm. It’s not clear whether she’ll be nominated to take on the role herself, but in the meantime, the White House has vetted an array of other candidates.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment